Analysis of the role of DAMTC in lung adenocarcinoma cells based on the DNA microarrays

Wang,Binliang; Cai,Yuanyuan; Kong,Yiming; Li,Xiaobo; Fu,Haiwei; Zhang,Song; Zhang,Tianwei

doi:10.3892/ol.2019.10146

Analysis of the role of DAMTC in lung adenocarcinoma cells based on the DNA microarrays

Authors:
- Binliang Wang
- Yuanyuan Cai
- Yiming Kong
- Xiaobo Li
- Haiwei Fu
- Song Zhang
- Tianwei Zhang
View Affiliations

Affiliations: Respiratory Medicine Department, Taizhou First People's Hospital, Taizhou, Zhejiang 318020, P.R. China
Published online on: March 15, 2019 https://doi.org/10.3892/ol.2019.10146
Pages: 4787-4794
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the effect of 7, 8‑diacetoxy‑4‑methylcoumarin (DAMTC) on lung adenocarcinoma cells (A549) and analyze the molecular mechanism underlying DAMTC‑treated lung adenocarcinoma. Gene expression profile GSE29698 was downloaded from the Gene Expression Omnibus database. The differentially expressed genes (DEGs) in 3 DAMTC‑treated A549 samples were analyzed and compared with 3 DAMTC‑untreated samples using the limma package. Gene Ontology (GO) and pathway enrichment analyses of DEGs were performed, followed by the functional annotation and protein‑protein interaction (PPI) network construction. Finally, pathway crosstalk analysis was conducted. A total of 500 upregulated and 389 downregulated DEGs were identified. The upregulated and downregulated DEGs were enriched in different GO terms and pathways, including metabolic process, p53 signaling pathway and metabolic pathways. A total of 9 DEGs were determined to have node degrees >16 in the PPI network, including interleukin 6 (IL6), MDM2 oncogene, E3 ubiquitin protein ligase (MDM2), cell division cycle 42 (CDC42) and MYC associated factor X (MAX). Furthermore, numerous DEGs were identified to function as transcription factors and tumor suppressor genes, including histone deacetylase 3 and MAX. Additionally, apoptosis, tight junction, and endocytosis pathway were determined to cross‑talk with small cell and non‑small cell lung cancer. The DEGs (IL6, MDM2, CDC42 and MAX) involved in different pathways, including the p53 signaling pathway and endocytosis, may be the potential targets for DAMTC in lung adenocarcinoma. The elucidation of the underlying mechanism of the DAMTC effect may make it a potential drug.

View Figures

View References

1	Goel A, Chhabra R, Ahmad S, Prasad A, Parmar V, Ghosh B and Saini N: DAMTC regulates cytoskeletal reorganization and cell motility in human lung adenocarcinoma cell line: An integrated proteomics and transcriptomics approach. Cell Death Dis. 3:e4022012. View Article : Google Scholar : PubMed/NCBI
2	Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al: Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
3	Kaisermann MC, Trajman A and Madi K: Evolving features of lung adenocarcinoma in Rio de Janeiro, Brazil. Oncol Rep. 8:189–192. 2001.PubMed/NCBI
4	Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M, Sivachenko A, et al: Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 150:1107–1120. 2012. View Article : Google Scholar : PubMed/NCBI
5	Borges F, Roleira F, Milhazes N, Santana L and Uriarte E: Simple coumarins and analogues in medicinal chemistry: Occurrence, synthesis and biological activity. Curr Med Chem. 12:887–916. 2005. View Article : Google Scholar : PubMed/NCBI
6	Musa MA, Cooperwood JS and Khan MO: A review of coumarin derivatives in pharmacotherapy of breast cancer. Curr Med Chem. 15:2664–2679. 2008. View Article : Google Scholar : PubMed/NCBI
7	Kostova I, Raleva S, Genova P and Argirova R: Structure-activity relationships of synthetic coumarins as HIV-1 inhibitors. Bioinorg Chem Appl. 682742006.PubMed/NCBI
8	Kontogiorgis CA and Hadjipavlou-Litina DJ: Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage. Bioorg Med Chem Lett. 14:611–614. 2004. View Article : Google Scholar : PubMed/NCBI
9	Appendino G, Mercalli E, Fuzzati N, Arnoldi L, Stavri M, Gibbons S, Ballero M and Maxia A: Antimycobacterial coumarins from the sardinian giant fennel (Ferula communis). J Nat Prod. 67:2108–2110. 2004. View Article : Google Scholar : PubMed/NCBI
10	Lacy A and O'Kennedy R: Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des. 10:3797–3811. 2004. View Article : Google Scholar : PubMed/NCBI
11	Goel A, Prasad A, Parmar V, Ghosh B and Saini N: Antiproliferative effects of 7, 8 diacetoxy 4 methyl coumarin and 7, 8 diacetoxy 4 methyl thiocoumarin in human lung adenocarcinoma cell line. Clin Cancer Res. 13:C38. 2007.
12	Goel A, Prasad AK, Parmar VS, Ghosh B and Saini N: Apoptogenic effect of 7, 8-diacetoxy-4-methylcoumarin and 7, 8-diacetoxy-4-methylthiocoumarin in human lung adenocarcinoma cell line: Role of NF-kappaB, Akt, ROS and MAP kinase pathway. Chem Biol Interact. 179:363–374. 2009. View Article : Google Scholar : PubMed/NCBI
13	Smyth GK: Limma: Linear models for microarray data. In: Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Gentleman R, Carey VJ, Huber W, Irizarry RA and Dudoit S: Springer; New York, NY: pp. 397–420. 2005
14	Reiner-Benaim A: FDR Control by the BH Procedure for two-sided correlated tests with implications to gene expression data analysis. Biom J. 49:107–126. 2007. View Article : Google Scholar : PubMed/NCBI
15	Benjamini Y and Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological). 57:289–300. 1995. View Article : Google Scholar
16	Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al: Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
17	Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
18	Kanehisa M and Goto S: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30. 2000. View Article : Google Scholar : PubMed/NCBI
19	Du P, Feng G, Flatow J, Song J, Holko M, Kibbe WA and Lin SM: From disease ontology to disease-ontology lite: Statistical methods to adapt a general-purpose ontology for the test of gene-ontology associations. Bioinformatics. 25:i63–i68. 2009. View Article : Google Scholar : PubMed/NCBI
20	Matys V, Fricke E, Geffers R, Gössling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, et al: TRANSFAC: Transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31:374–378. 2003. View Article : Google Scholar : PubMed/NCBI
21	Köhler S, Bauer S, Horn D and Robinson PN: Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet. 82:949–958. 2008. View Article : Google Scholar : PubMed/NCBI
22	Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C and Jensen LJ: STRING v9. 1: Protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41:(Database Issue). D808–D815. 2013. View Article : Google Scholar : PubMed/NCBI
23	Von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P and Snel B: STRING: A database of predicted functional associations between proteins. Nucleic Acids Res. 31:258–261. 2003. View Article : Google Scholar : PubMed/NCBI
24	Li Y, Agarwal P and Rajagopalan D: A global pathway crosstalk network. Bioinformatics. 24:1442–1447. 2008. View Article : Google Scholar : PubMed/NCBI
25	Liu ZP, Wang Y, Zhang XS and Chen L: Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains. BMC Syst Biol. 4 Suppl 2:S112010. View Article : Google Scholar : PubMed/NCBI
26	Cooper S and Spiro SG: Small cell lung cancer: Treatment review. Respirology. 11:241–248. 2006. View Article : Google Scholar : PubMed/NCBI
27	Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, et al: Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in crohn disease and experimental colitis in vivo. Nat Med. 6:583–588. 2000. View Article : Google Scholar : PubMed/NCBI
28	Hodge DR, Hurt EM and Farrar WL: The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer. 41:2502–2512. 2005. View Article : Google Scholar : PubMed/NCBI
29	Fesik SW: Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer. 5:876–885. 2005. View Article : Google Scholar : PubMed/NCBI
30	Nicholson DW: From bench to clinic with apoptosis-based therapeutic agents. Nature. 407:810–816. 2000. View Article : Google Scholar : PubMed/NCBI
31	Lüscher B: Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene. 277:1–14. 2001. View Article : Google Scholar : PubMed/NCBI
32	Grandori C, Cowley SM, James LP and Eisenman RN: The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol. 16:653–699. 2000. View Article : Google Scholar : PubMed/NCBI
33	Zhu J, Blenis J and Yuan J: Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1. Proc Natl Acad Sci USA. 105:6584–6589. 2008. View Article : Google Scholar : PubMed/NCBI
34	Goel A, Chhabra R, Ahmad S, Prasad AK, Parmar VS, Ghosh B and Saini N: DAMTC regulates cytoskeletal reorganization and cell motility in human lung adenocarcinoma cell line: An integrated proteomics and transcriptomics approach. Cell Death Dis. 3:e4022012. View Article : Google Scholar : PubMed/NCBI
35	Stevenson LF, Sparks A, Allende-Vega N, Xirodimas DP, Lane DP and Saville MK: The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2. EMBO J. 26:976–986. 2007. View Article : Google Scholar : PubMed/NCBI
36	Oren M: Decision making by p53: Life, death and cancer. Cell Death Differ. 10:431–442. 2003. View Article : Google Scholar : PubMed/NCBI
37	Pula G and Poole AW: Critical roles for the actin cytoskeleton and cdc42 in regulating platelet integrin alpha2beta1. Platelets. 19:199–210. 2008. View Article : Google Scholar : PubMed/NCBI
38	Georgiou M, Marinari E, Burden J and Baum B: Cdc42, Par6 and aPKC regulate Arp2/3-mediated endocytosis to control local adherens junction stability. Curr Biol. 18:1631–1638. 2008. View Article : Google Scholar : PubMed/NCBI
39	Mosesson Y, Mills GB and Yarden Y: Derailed endocytosis: An emerging feature of cancer. Nat Rev Cancer. 8:835–850. 2008. View Article : Google Scholar : PubMed/NCBI